Search research articles
Contact Us
Filters
Showing results (31-40 of 35) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 35 results.
British Journal of Cancer
|
July 29, 2010
Integrated preclinical and clinical development of mTOR inhibitors in pancreatic cancer
I Garrido-Laguna, A C Tan, M Uson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 21, 2015
A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreatic cancer
B H O'Neil, A J Scott, W W Ma, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 23, 2015
A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreatic cancer
B H O'Neil, A J Scott, W W Ma, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 6, 2016
A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreatic cancer
B H O'Neil, A J Scott, W W Ma, et al.
Zhonghua Kou Qiang Yi Xue Za Zhi = Zhonghua Kouqiang Yixue Zazhi = Chinese Journal of Stomatology
|
November 27, 2025
[Consensus on informed consent for orthodontic treatment]
Y Cao, B Fang, Z L Jin, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 35) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 35 results.
British Journal of Cancer
|
July 29, 2010
Integrated preclinical and clinical development of mTOR inhibitors in pancreatic cancer
I Garrido-Laguna, A C Tan, M Uson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 21, 2015
A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreatic cancer
B H O'Neil, A J Scott, W W Ma, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 23, 2015
A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreatic cancer
B H O'Neil, A J Scott, W W Ma, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 6, 2016
A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreatic cancer
B H O'Neil, A J Scott, W W Ma, et al.
Zhonghua Kou Qiang Yi Xue Za Zhi = Zhonghua Kouqiang Yixue Zazhi = Chinese Journal of Stomatology
|
November 27, 2025
[Consensus on informed consent for orthodontic treatment]
Y Cao, B Fang, Z L Jin, et al.
Page
of 4